Pharmosa Biopharm Inc. (6875.TWO)
TWD 51.5
(2.18%)
TWD 51.5
(2.18%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 8.45 Million TWD | 103.17% |
| 2022 | -266.5 Million TWD | -3.91% |
| 2021 | -256.47 Million TWD | -41.16% |
| 2020 | -181.69 Million TWD | -40.17% |
| 2019 | -129.62 Million TWD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -58.6 Million TWD | -10.75% |
| 2024 Q1 | -52.92 Million TWD | 42.07% |
| 2023 Q3 | 230.65 Million TWD | 442.75% |
| 2023 FY | 8.45 Million TWD | 103.17% |
| 2023 Q4 | -91.35 Million TWD | -139.6% |
| 2023 Q2 | -67.29 Million TWD | -5.89% |
| 2023 Q1 | -63.55 Million TWD | -40.58% |
| 2022 Q4 | -45.2 Million TWD | 27.12% |
| 2022 Q3 | -62.03 Million TWD | 0.0% |
| 2022 FY | -266.5 Million TWD | -3.91% |
| 2021 FY | -256.47 Million TWD | -41.16% |
| 2020 FY | -181.69 Million TWD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 251.01 Million TWD | 96.631% |
| Level Biotechnology Inc. | 62.9 Million TWD | 86.558% |
| TaiMed Biologics Inc. | -194.81 Million TWD | 104.341% |
| GlycoNex Incorporation | -178.36 Million TWD | 104.741% |
| GeneReach Biotechnology Corp. | -166.27 Million TWD | 105.086% |
| OBI Pharma, Inc. | -1.04 Billion TWD | 100.808% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -10.68 Million TWD | 179.161% |
| Genomics BioSci & Tech. Co.,Ltd. | -168.06 Million TWD | 105.031% |
| Visgeneer Inc. | -19.58 Million TWD | 143.167% |
| Neith Corporation | -40.03 Million TWD | 121.123% |
| Lumosa Therapeutics Co., Ltd. | -238.04 Million TWD | 103.552% |
| Medigen Vaccine Biologics Corporation | -1.15 Billion TWD | 100.729% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.04 Million TWD | 239.838% |
| Enimmune corporation | -223.74 Million TWD | 103.779% |
| TaiRx, Inc. | -212.29 Million TWD | 103.983% |
| CHO Pharma, Inc. | -306.08 Million TWD | 102.763% |
| BioLASCO Taiwan Co., Ltd. | 49.74 Million TWD | 83.001% |
| Sunny Pharmtech Inc. | -63.32 Million TWD | 113.354% |
| Ever Supreme Bio Technology Co., Ltd | 539.39 Million TWD | 98.432% |
| Feng Chi Biotech Corp. | 22.79 Million TWD | 62.899% |
| Lukas Biomedical Inc. | -47.35 Million TWD | 117.857% |
| RBC Bioscience Corporation | 6.43 Million TWD | -31.509% |
| NaviFUS Corp. | -65.72 Million TWD | 112.865% |
| BRIM Biotechnology, Inc. | -688.02 Million TWD | 101.229% |
| Shine-On BioMedical Co.,Ltd. | -37.16 Million TWD | 122.753% |
| Great Novel Therapeutics Biotech & Medicals | -61.54 Million TWD | 113.741% |
| Sagittarius Life Science Corp | -55.03 Million TWD | 115.364% |
| Bio Preventive Medicine Corp. | -73.28 Million TWD | 111.539% |
| Advagene Biopharma Co., Ltd. | -92.11 Million TWD | 109.18% |
| BioGend Therapeutics Co., Ltd. | -156.32 Million TWD | 105.409% |
| G&E Herbal Biotechnology Co., Ltd. | 72.4 Million TWD | 88.32% |
| Andros Pharmaceuticals Co.,Ltd | -68.15 Million TWD | 112.406% |
| Lin BioScience, Inc. | -687.19 Million TWD | 101.231% |
| Anti-Microbial Savior BioteQ Co., Ltd | -51.78 Million TWD | 116.33% |
| AP Biosciences Inc | -339.29 Million TWD | 102.492% |
| Sunmax Biotechnology Co., Ltd. | 625.7 Million TWD | 98.649% |
| Syngen Biotech Co.,Ltd. | 274.82 Million TWD | 96.923% |
| EirGenix Inc. | -915.2 Million TWD | 100.924% |
| Mycenax Biotech Inc. | -682.84 Million TWD | 101.238% |
| SynCore Biotechnology Co.,Ltd | -38.17 Million TWD | 122.152% |
| Eusol Biotech Co.,Ltd. | -51.61 Million TWD | 116.383% |
| NeoCore Technology Co., Ltd. | -64.64 Million TWD | 113.081% |
| VBI | -6.6 Million TWD | 228.102% |
| BiOptic Inc. | 37.74 Million TWD | 77.598% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -88.08 Million TWD | 109.599% |
| Sinew Pharma Inc. | -170.92 Million TWD | 104.947% |
| Greenyn Biotechnology Co., Ltd | 130.66 Million TWD | 93.528% |
| Medigen Biotechnology Corp. | -561.29 Million TWD | 101.507% |
| 3D Global Biotech Inc. | -57.95 Million TWD | 114.592% |
| Intech Biopharm Corporation | -337.98 Million TWD | 102.502% |
| Oneness Biotech Co., Ltd. | -1.31 Billion TWD | 100.644% |
| TWi Biotechnology, Inc. | -170.68 Million TWD | 104.954% |
| TCI GENE Inc. | 11.67 Million TWD | 27.559% |
| MegaPro Biomedical Co., Ltd | -127.54 Million TWD | 106.63% |
| Senhwa Biosciences, Inc. | -296.3 Million TWD | 102.854% |
| Taiwan Bio Therapeutics Co., Ltd | -217.51 Million TWD | 103.888% |
| NatureWise Biotech & Medicals Corporation | 10.12 Million TWD | 16.443% |
| PharmaEngine, Inc. | 274.65 Million TWD | 96.921% |
| Savior Lifetec Corporation | 30.03 Million TWD | 71.841% |
| TaiGen Biopharmaceuticals Holdings Limited | 136.73 Million TWD | 93.816% |
| Meribank Biotech Co., Ltd | -125.34 Million TWD | 106.746% |
| Acepodia, Inc. | -817.31 Million TWD | 101.035% |
| Caliway Biopharmaceuticals Co., Ltd. | -488.45 Million TWD | 101.731% |